Yoshiaki Zaizen

Kurume, 8300011, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Progressive Fibrosing Lung Disease Treated With Nintedanib in a Patient With Long-Standing Autoimmune Pulmonary Alveolar Proteinosis: A Case Report.

Progressive Fibrosing Lung Disease Treated With Nintedanib in a Patient With Long-Standing Autoimmune Pulmonary Alveolar Proteinosis: A Case Report.

Journal: Case reports in pulmonology

Published: June 12, 2026

Expression of melanoma differentiation-associated gene 5 in the epidermis and cutaneous deposition of complement C3 and immunoglobulins in patients with dermatomyositis.

Expression of melanoma differentiation-associated gene 5 in the epidermis and cutaneous deposition of complement C3 and immunoglobulins in patients with dermatomyositis.

Journal: PloS one

Published: February 09, 2026

Association of the lower-lobe volume ratio on three-dimensional computed tomography with disease progression in idiopathic pulmonary fibrosis.

Association of the lower-lobe volume ratio on three-dimensional computed tomography with disease progression in idiopathic pulmonary fibrosis.

Journal: Respiratory investigation

Published: January 27, 2026

A proposed pathological diagnosis flowchart for adult interstitial lung disease with transbronchial lung cryobiopsy: Position paper from the Japanese research group on diffuse lung disease.

A proposed pathological diagnosis flowchart for adult interstitial lung disease with transbronchial lung cryobiopsy: Position paper from the Japanese research group on diffuse lung disease.

Journal: Respiratory investigation

Published: January 11, 2026

Multifocal micronodular pneumocyte hyperplasia in the absence of tuberous sclerosis complex: A case report.

Multifocal micronodular pneumocyte hyperplasia in the absence of tuberous sclerosis complex: A case report.

Journal: Radiology case reports

Published: October 25, 2025

Complement activation and M2-like macrophage accumulation in anti-MDA5 monoclonal antibody-induced hepatic injury in mice.

Complement activation and M2-like macrophage accumulation in anti-MDA5 monoclonal antibody-induced hepatic injury in mice.

Journal: Frontiers in immunology

Published: September 17, 2025

Three-dimensional computed tomography lung volume analysis associates with the presence of pathological usual interstitial pneumonia in interstitial lung disease.

Three-dimensional computed tomography lung volume analysis associates with the presence of pathological usual interstitial pneumonia in interstitial lung disease.

Journal: Respiratory investigation

Published: August 26, 2025

Volume histogram analysis of whole-lung CT: differentiating usual from nonspecific interstitial pneumonias and predicting prognosis.

Volume histogram analysis of whole-lung CT: differentiating usual from nonspecific interstitial pneumonias and predicting prognosis.

Journal: Japanese journal of radiology

Published: August 22, 2025

Gene variants of interferon induced with helicase C domain 1 in Japanese patients with Dermatomyositis-associated rapidly progressive interstitial lung disease: a genetic association study using whole-exome and Sanger sequencing.

Gene variants of interferon induced with helicase C domain 1 in Japanese patients with Dermatomyositis-associated rapidly progressive interstitial lung disease: a genetic association study using whole-exome and Sanger sequencing.

Journal: Respiratory research

Published: August 02, 2025

Pathologic Findings of Pulmonary Lymphoproliferative Disorders.

Pathologic Findings of Pulmonary Lymphoproliferative Disorders.

Journal: Seminars in ultrasound, CT, and MR

Published: July 03, 2025

Imaging of Diseases Involving Pulmonary Lymphatics: Focus on Pulmonary Sarcoidosis.

Imaging of Diseases Involving Pulmonary Lymphatics: Focus on Pulmonary Sarcoidosis.

Journal: Seminars in ultrasound, CT, and MR

Published: June 28, 2025

Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD).

Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD).

Journal: ERJ open research

Published: May 22, 2025

Showing 1-12 of 82

Last Updated: 09/26/2026